LVGO - Teledoc rallies in pre-market after being named a 'surefire growth stock'

Teladoc Health (TDOC) is +1.4% in pre-market trading as Motley Fool author, Danny Vena, names it as among ‘3 Surefire Growth Stocks to Buy Before 2021.’Citing the company’s exponential revenue growth, and the recent acquisition of chronic-care specialist Livongo (LVGO), Vena says Teladoc is best positioned to capitalize on the growing trend towards telehealth and telemedicine, which was accelerated by the COVID-19 pandemic.With even a stronger adoption of the platform in the home bastion of U.S., the company saw a two-fold rise in revenue in Q3 2020, notes the author, adding that its international growth, making up only a small fraction of business ‘has only just begun.’The acquisition of Livongo Health, which had triple-digit growth before the merger, will ‘cement the company's leadership in virtual care.’ concludes Vena.Seeking Alpha author, DTF Capital ‘expect the merger will be a success’ citing Teladoc’s strong track record of successful integration and Livongo’s differentiated offerings.’

For further details see:

Teledoc rallies in pre-market after being named a ‘surefire growth stock’